Haisco Enters into Exclusive License Agreement with AbbVie to Develop Novel Medicines for Pain

B BEIJING, April 13, 2026 /PRNewswire/ — On April 10, 2026, Haisco Pharmaceutical Group Co., Ltd. (Ticker Code: 002653) announced that it has entered into an…
posteditor
posteditor
Articles: 16137

Other News